NO144111C - Fremgangsmaate ved fremstilling av immunoglobulinderivater - Google Patents

Fremgangsmaate ved fremstilling av immunoglobulinderivater

Info

Publication number
NO144111C
NO144111C NO750768A NO750768A NO144111C NO 144111 C NO144111 C NO 144111C NO 750768 A NO750768 A NO 750768A NO 750768 A NO750768 A NO 750768A NO 144111 C NO144111 C NO 144111C
Authority
NO
Norway
Prior art keywords
procedure
preparation
immunoglobulin derivatives
immunoglobulin
derivatives
Prior art date
Application number
NO750768A
Other languages
English (en)
Norwegian (no)
Other versions
NO144111B (no
NO750768L (sv
Inventor
Katsuhiko Tomibe
Yasuhiko Masuho
Kimihiko Matsuzawa
Sachio Ishimoto
Kazuo Satake
Tsuneo Watanabe
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2634174A external-priority patent/JPS5417721B2/ja
Priority claimed from JP7127474A external-priority patent/JPS511630A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of NO750768L publication Critical patent/NO750768L/no
Publication of NO144111B publication Critical patent/NO144111B/no
Publication of NO144111C publication Critical patent/NO144111C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO750768A 1974-03-08 1975-03-07 Fremgangsmaate ved fremstilling av immunoglobulinderivater NO144111C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2634174A JPS5417721B2 (sv) 1974-03-08 1974-03-08
JP7127474A JPS511630A (ja) 1974-06-24 1974-06-24 Jomyakuchushayomenekiguroburinno seizoho

Publications (3)

Publication Number Publication Date
NO750768L NO750768L (sv) 1975-09-09
NO144111B NO144111B (no) 1981-03-16
NO144111C true NO144111C (no) 1981-06-24

Family

ID=26364115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750768A NO144111C (no) 1974-03-08 1975-03-07 Fremgangsmaate ved fremstilling av immunoglobulinderivater

Country Status (12)

Country Link
US (1) US4059571A (sv)
CA (1) CA1041997A (sv)
CH (1) CH614426A5 (sv)
DD (1) DD118655A5 (sv)
DE (2) DE2560155C2 (sv)
DK (1) DK141432B (sv)
FR (1) FR2262996B1 (sv)
GB (1) GB1497928A (sv)
IN (1) IN138636B (sv)
NL (1) NL167167C (sv)
NO (1) NO144111C (sv)
SE (1) SE403703B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658334B2 (de) * 1976-12-23 1980-06-04 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Immunglobulinpraparationen mit verminderter Komplementbindung und ein diese enthaltendes Arzneimittel
JPS5598117A (en) * 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
DE2953674C2 (de) * 1979-05-23 1986-04-24 Teijin Ltd., Osaka Verfahren zur Herstellung von menschlichen Immungammaglobulinderivaten
US4362661A (en) * 1979-08-09 1982-12-07 Teijin Limited Immunoglobulin composition having a high monomer content, and process for production thereof
US4360457A (en) * 1979-08-30 1982-11-23 Teijin Limited S-Sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
JPS56113713A (en) * 1980-02-14 1981-09-07 Chemo Sero Therapeut Res Inst Preparation of immunoglobulin with high content of monomer
JPS5821623A (ja) * 1981-07-28 1983-02-08 Tetsuzo Sugizaki 抗原抗体複合体沈着疾患治療剤
US4479895A (en) * 1982-05-05 1984-10-30 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
CA2082265A1 (en) * 1990-05-07 1991-11-08 Chien-Hsing Chang Method for radiolabeling monovalent antibody fragments
DK2236154T3 (en) * 2003-02-10 2018-06-25 Biogen Ma Inc IMMUNOGLOBULIN INFORMATION AND METHOD OF PREPARING IT

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m

Also Published As

Publication number Publication date
NL7502745A (nl) 1975-09-10
DE2508132A1 (de) 1975-09-11
GB1497928A (en) 1978-01-12
AU7872975A (en) 1976-09-09
NL167167B (nl) 1981-06-16
DK141432B (da) 1980-03-17
IN138636B (sv) 1976-03-06
FR2262996A1 (sv) 1975-10-03
FR2262996B1 (sv) 1982-01-29
DE2560155C2 (de) 1984-04-26
NO144111B (no) 1981-03-16
CH614426A5 (sv) 1979-11-30
DK141432C (sv) 1980-09-15
DE2508132B2 (de) 1980-02-21
DE2508132C3 (de) 1980-10-16
NO750768L (sv) 1975-09-09
SE7502346L (sv) 1975-09-09
DD118655A5 (sv) 1976-03-12
SE403703B (sv) 1978-09-04
DK93475A (sv) 1975-09-09
US4059571A (en) 1977-11-22
NL167167C (nl) 1981-11-16
CA1041997A (en) 1978-11-07

Similar Documents

Publication Publication Date Title
NO148712C (no) Fremgangsmaate ved fremstilling av etylidendiacetat
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7513085L (sv) Forfarande for framstellning av etrar
SE7511408L (sv) Forfarnde for framstellning av karbamid- eller tiokarbamidderivat
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
NO144111C (no) Fremgangsmaate ved fremstilling av immunoglobulinderivater
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
NO143224C (no) Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE424548B (sv) Forfarande for framstellning av alkylsulfonylfenoxipropanolaminer